We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

57 hedge funds and large institutions have $31M invested in Ampio Pharmaceuticals Inc. in 2015 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

118% more call options, than puts

Call options by funds: $1.7M | Put options by funds: $780K

24% more capital invested

Capital invested by funds: $25M → $31M (+$6M)

12% more funds holding

Funds holding: 51 → 57 (+6)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

25% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 12

Holders
57
Holders Change
+6
Holders Change %
+11.76%
% of All Funds
1.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
9
Reduced
12
Closed
3
Calls
$1.7M
Puts
$780K
Net Calls
+$924K
Net Calls Change
+$575K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$629K
2
FPCP
Fort Point Capital Partners
California
+$306K
3
BCM
Bluefin Capital Management
New York
+$189K
4
OAM
Oxford Asset Management
United Kingdom
+$158K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$126K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$442K
2
Goldman Sachs
Goldman Sachs
New York
-$295K
3
Morgan Stanley
Morgan Stanley
New York
-$113K
4
TMC
Trellus Management Company
Florida
-$107K
5
UBS Group
UBS Group
Switzerland
-$61.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
26
American International Group
New York
$93K – – –
FIM
27
Frontier Investment Management
Texas
$83K – – –
Goldman Sachs
28
Goldman Sachs
New York
$80K -$295K -298 -80%
California Public Employees Retirement System
29
California Public Employees Retirement System
California
$72K – – –
Dimensional Fund Advisors
30
Dimensional Fund Advisors
Texas
$72K – – –
OC
31
Oppenheimer & Co
New York
$70K – – –
LPL Financial
32
LPL Financial
California
$69K +$14.8K +15 +26%
OWP
33
Obermeyer Wealth Partners
Colorado
$68K – – –
UBS Group
34
UBS Group
Switzerland
$66K -$61.4K -62 -50%
EGA
35
Eagle Global Advisors
Texas
$61K -$14.8K -15 -21%
Brown Advisory
36
Brown Advisory
Maryland
$58K – – –
JWA
37
JFS Wealth Advisors
Pennsylvania
$58K – – –
CC
38
Courier Capital
New York
$53K – – –
Citadel Advisors
39
Citadel Advisors
Florida
$43K +$40.6K +41 New
PAM
40
Panagora Asset Management
Massachusetts
$38K +$35.6K +36 New
WA
41
WealthTrust Axiom
Pennsylvania
$35K – – –
Simplex Trading
42
Simplex Trading
Illinois
$34K -$11.9K -12 -27%
SB
43
Suntrust Banks
Georgia
$34K +$35.6K +36 New
BA
44
BlackRock Advisors
Delaware
$31K – – –
CG
45
Cutler Group
California
$29K +$27.7K +28 New
BIM
46
BlackRock Investment Management
Delaware
$27K – – –
IA
47
IFP Advisors
Florida
$21K +$19.8K +20 New
PNC Financial Services Group
48
PNC Financial Services Group
Pennsylvania
$18K -$1.98K -2 -11%
Citigroup
49
Citigroup
New York
$15K -$4.95K -5 -25%
CP
50
Corbenic Partners
Pennsylvania
$14K – – –
1
2
3

AMPE Hedge Fund Activity: Q4 2015 in Review

57 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q4 2015, worth a combined $31M — up 24% from $25M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new AMPE positions and 3 closed out — a net gain of 6 holders — while 9 added to existing stakes and 12 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $629K. The largest seller was Millennium Management, cutting an estimated $442K.

  • 57 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q4 2015, up from 51 in Q3 2015.
  • Funds reported $31M of Ampio Pharmaceuticals Inc. stock for Q4 2015, up 24% quarter-over-quarter.
  • 9 funds opened new Ampio Pharmaceuticals Inc. positions in Q4 2015 and 3 closed out, a net change of +6 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q4 2015 was Susquehanna International Group, an estimated $629K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q4 2015 was Millennium Management, an estimated $442K sold.

Based on aggregated 13F filings for Q4 2015.